IVM is on the list of about 8 therapeutics that are used to address about 14 key biomarkers that were identified by AI machine learning techniques derived from a large candidate set of biomarkers taken from key groups of people with long haul type syndromes: Long Haul Post COVID, Long Haul Post COVID vaccine, Long haul ME/CFS chronic fatigue, long haul post Lyme, fibromyalgia. The results show the commonalities and differences between these syndromes. There is a key finding of persistent antigen fragments in monocytes driving COVID syndromes. Of the 14 biomarkers needed to treat, and about 8 compounds that Patterson and colleagues are focusing on, Ivermectin is one of them.
Also papers by my friend David Scheim:
(I commented on the second manuscript before it went out.)
The first talks about how a mild cold virus turned deadly by undermining a process to prevent hemagglutination. Clumping of red blood cells.
The second paper discusses how in vitro IVM is a tool that will undo or return to healthy state the rouleaux formations in blood cells if at at their early stage. An exciting find.
And the evidence mounts ... meanwhile, covid patients are told to take dangerous horse medicine. - "Molnupiravir began as a possible therapy for Venezuelan equine encephalitis virus at Emory University’s non-profit company DRIVE (Drug Innovation Ventures at Emory) in Atlanta." https://www.nature.com/articles/d41586-021-02783-1
Que narrative pivot to "just because it was originally developed for horses doesn't mean it's horse medicine", from the same gaslighters who brought us "you're not a horse, you're not a cow, seriously y'all, stop it". (Or they'll hope no one notices the equine detail .. or the mutagenic potential .. ( what could go wrong? ))
The following bodies of work should be integrated into your thesis, building your case.
Bruce Patterson's work: https://www.youtube.com/watch?v=h2xyWiMS2Q0
IVM is on the list of about 8 therapeutics that are used to address about 14 key biomarkers that were identified by AI machine learning techniques derived from a large candidate set of biomarkers taken from key groups of people with long haul type syndromes: Long Haul Post COVID, Long Haul Post COVID vaccine, Long haul ME/CFS chronic fatigue, long haul post Lyme, fibromyalgia. The results show the commonalities and differences between these syndromes. There is a key finding of persistent antigen fragments in monocytes driving COVID syndromes. Of the 14 biomarkers needed to treat, and about 8 compounds that Patterson and colleagues are focusing on, Ivermectin is one of them.
Also papers by my friend David Scheim:
(I commented on the second manuscript before it went out.)
The first talks about how a mild cold virus turned deadly by undermining a process to prevent hemagglutination. Clumping of red blood cells.
From Cold to Killer
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3706347
The second paper discusses how in vitro IVM is a tool that will undo or return to healthy state the rouleaux formations in blood cells if at at their early stage. An exciting find.
A Deadly Embrace
https://www.mdpi.com/1422-0067/23/5/2558
David also published a review article on IVM for COVID with some well known folks:
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
Santin, Scheim, McCullough, Yagisawa, Borody
https://pubmed.ncbi.nlm.nih.gov/34466270/
A few more papers are in the works, will keep you posted.
And the evidence mounts ... meanwhile, covid patients are told to take dangerous horse medicine. - "Molnupiravir began as a possible therapy for Venezuelan equine encephalitis virus at Emory University’s non-profit company DRIVE (Drug Innovation Ventures at Emory) in Atlanta." https://www.nature.com/articles/d41586-021-02783-1
Que narrative pivot to "just because it was originally developed for horses doesn't mean it's horse medicine", from the same gaslighters who brought us "you're not a horse, you're not a cow, seriously y'all, stop it". (Or they'll hope no one notices the equine detail .. or the mutagenic potential .. ( what could go wrong? ))
Walter, If this holds true isn't this a case for IVM as importantly for prophylaxis use?